This work stemmed from the initial observation that decreasing cAMP-PKA activity, either by overproducing
BCY1 or
PDE2 or by deleting
RAS2, rescued the lethality of
spc24 kinetochore mutants ( and ). In addition, we had previously identified genetic interactions between
pde2 and
ira2, which are mutants of negative regulators of the cAMP-PKA pathway, and
spc24 mutants (
Montpetit et al. 2005). A simple model of these observations is that the cAMP-PKA pathway inhibits kinetochore function. However, our data suggest that the interaction between the cAMP-PKA pathway and the kinetochore is more complex. Inhibition of PKA activity is beneficial to the growth of
spc24 and
ipl1-321 mutants but detrimental to the
ndc10-1 mutant, in which no kinetochore is assembled, and the
spc24-8 mad2Δ double mutant, in which the spindle checkpoint has been abolished (). In addition, all kinetochore mutants, except for the spindle checkpoint proficient
spc24-8 mutant, have higher levels of PKA activity ( and ). The increased PKA activity is not due to accumulation of cells in metaphase or anaphase because during an unperturbed cell cycle, PKA-dependent
Msn2 phosphorylation levels remain constant (). As well, metaphase-arrested cells have low levels of PKA activity (). Therefore, defects in the kinetochore, and not cell cycle arrest, cause an increase in PKA activity. Finally, we show that reduction of PKA activity rescues chromosome loss defects of the
ndc10-1 mutant at a permissive temperature (). Therefore, the kinetochore is highly sensitive to fluctuations in PKA activity.
We demonstrate that, in addition to suppression of lethality by lowering PKA activity, mutants of the
Ndc80 kinetochore complex are sensitive to glucose, and their growth defects are suppressed on nonfermentable carbon sources (). It was shown previously that mutants of the APC are also suppressed by reducing Ras signaling and growth on nonglucose carbon sources (
Irniger et al. 2000). Therefore, we expected that all kinetochore mutants that were rescued by reducing PKA signaling would preferentially grow on nonglucose carbon sources. However, we tested a variety of kinetochore mutants in addition to the mutants presented here and found no strict correlation between growth rescue by inhibition of PKA signaling and growth rescue on nonglucose carbon sources. For example, a strain carrying a mutation in
CTF13, which codes for a protein in the
CBF3 inner kinetochore complex, displayed no growth changes upon overexpression of
BCY1 but was rescued by growth on glycerol or galactose media (data not shown). The growth of the
ipl1-321 mutant is improved upon deletion of
RAS2 or overexpression of
BCY1 but not when plated on nonfermentable carbon sources (, , and ). Although the viability of all mutants of the
Ndc80 kinetochore complex was rescued by reducing PKA signaling or plating on a nonglucose carbon source, mutants of other kinetochore complexes, such as the
CBF3, COMA, and
Dam1 complexes, displayed variable phenotypes (data not shown). Therefore, the sensitivity of kinetochore mutants to fluctuations in PKA activity is not strictly correlated to the presence of glucose in the media.
The chromosome loss defect of
ndc10-1 cells is reduced by 20-fold upon deletion of
RAS2 and 4-fold overexpression of
BCY1 at 25° (). However, when grown at 30°, we find that overexpression of
BCY1 causes lethality to
ndc10-1 strains and that
ndc10-1 ras2Δ strains grow more poorly than do
ndc10-1 strains at 32° ( and ). At a permissive temperature, kinetochore complexes still associate with centromere DNA in the
ndc10-1 mutant, whereas at a restrictive temperature, no kinetochore complexes are able to assemble on the centromere (
He et al. 2001;
Janke et al. 2001;
Nekrasov et al. 2003;
Ortiz et al. 1999). Therefore, lowering PKA activity only rescues CF loss of the
ndc10-1 mutant when there is an assembled kinetochore that is able to attach to microtubules. Perhaps this is why we did not detect rescue of CF loss in
ipl1-321 or
spc24-9 mutants in which kinetochore-microtubule attachment is impaired.
We find that the
ipl1-321 growth defect is suppressed by overexpression of
PDE2 and
BCY1 or by deletion of
RAS2, all of which lower PKA activity ( and ). In addition, expression of the dominant
RASval19 allele is detrimental to
ipl1-321 growth (). The rescue of
ipl1-321 growth defect by lowering PKA activity is intriguing in light of recent data demonstrating that reduction of target of rapamycin (TOR) complex 1 (TORC1) activity also suppresses the growth defect of an
ipl1-2 mutant (
Tatchell et al. 2011). TOR and PKA are the two major signaling pathways that activate cell growth in response to nutrients by regulating processing, such as translation, ribosome biogenesis, and glucose metabolism (
Smets et al. 2010;
Soulard et al. 2009). TORC1 and PKA have been shown to regulate common target proteins, and recent data demonstrate that TOR can activate PKA toward a subset of substrates (
Soulard et al. 2010). Reduction of TORC1 activity suppressed the chromosome loss defect in
ipl1-2 mutants, whereas we did not detect rescue of CF loss in
ipl1-321 mutants upon reduction of PKA activity (
Tatchell et al. 2011). Nonetheless, our data combined with
Tatchell et al. (2011) strongly support a link between nutritional status and kinetochore function.
Activation of the PKA pathway is known to be inhibitory to the APC, possibly via phosphorylation of
Cdc20 (
Anghileri et al. 1999;
Bolte et al. 2003;
Irniger et al. 2000;
Searle et al. 2004). For example, the growth defect of
apc10-22 mutants, which stabilizes
Pds1, is suppressed by deletion of
RAS2 (
Irniger et al. 2000). Stabilization of
Pds1 (securin) prevents chromosome separation due to inhibition of
Esp1 (separase). The APC is also inhibited, and
Pds1 is stabilized upon activation of the spindle checkpoint by the interaction of the
Mad2 checkpoint protein with
Cdc20 (
Clarke and Bachant 2008). However, no study has addressed the interaction between the PKA pathway and the spindle checkpoint. In this work, we monitored
Msn2 PKA-dependent phosphorylation in cells arrested in metaphase due to induction of the spindle checkpoint upon nocodazole treatment (). We found that
Msn2 PKA-dependent phosphorylation is reduced under these conditions, suggesting that PKA activity may be reduced during the spindle checkpoint. Interestingly, the only kinetochore mutant that did not display high levels of PKA activity was
spc24-8, which arrests in metaphase due to activation of the spindle checkpoint (
Montpetit et al. 2005) ( and ). It is possible that reducing PKA levels suppresses
spc24 and
ipl1 mutants due to spindle checkpoint activation; however, this does not explain why the viability of the
spc24-8 mutant, which is spindle checkpoint proficient, is improved by reducing PKA activity ( and ). Activation of the PKA pathway causes phosphorylation of the
Msn2 nuclear localization sequence on serine residues, prevention of
Msn2 nuclear import, and restoration of
Msn2 to the cytoplasm (
Gorner et al. 1998,
2002;
Jacquet et al. 2003). Inhibition of PKA activity upon nocodazole treatment might evoke a general stress response that results in dephosphorylation of
Msn2 and subsequent localization to the nucleus. In fact, microarray studies performed after treatment of yeast cells with benomyl, another microtubule poison, demonstrated that expression of
Msn2 genes is induced (
Lucau-Danila et al. 2005). Whether inhibition of PKA activity rescues
spc24 mutants due to activation of a
Msn2-dependent stress response remains to be tested.
Because it is difficult to separate the spindle checkpoint response from a general cell stress response upon addition of microtubule poisons, deletion of the
Mad2 spindle checkpoint protein is an alternative method to assess the spindle checkpoint. We find that overexpression of
BCY1 and
PDE2 only rescues viability of strains that have a partially assembled kinetochore and
Mad2 present in the cell (). For example, overexpression of
BCY1 and
PDE2 rescues the growth defect of the
spc24-8 (spindle checkpoint active) mutant but is detrimental to the growth of the
spc24-8 mad2Δ (spindle checkpoint defective) mutant ( and ). The APC specificity factor
Cdc20 is phosphorylated on PKA consensus sites after DNA damage, and inactivation of PKA accelerates
Pds1 destruction (
Searle et al. 2004). If phosphorylation of
Cdc20 by PKA prevents an interaction between
Cdc20 and
Mad2, then decreasing PKA activity may enrich the
Cdc20-
Mad2 interaction and spindle checkpoint response. If
Mad2 is not present, then decreasing PKA activity may accelerate
Pds1 destruction, which would force
spc24-8 mad2 cells into anaphase with defective chromosome attachments. One complication to this argument is that deletion of
RAS2 rescues the growth defect of both
spc24-8 and
spc24-8 mad2Δ strains ( and ). Likely, there is more than one mechanism by which a reduction in PKA activity rescues viability of kinetochore mutants.
An unexpected finding from our study is that kinetochore mutants have increased levels of PKA activity when grown at a semipermissive temperature ( and ). These data suggest that defects in the kinetochore may trigger activation of the PKA pathway, possibly via components of the cAMP-PKA pathway, that are nuclear localized.
Bcy1, the PKA regulatory subunit, is predominantly in the nucleus when cells are grown in glucose (
Griffioen et al. 2000). It remains to be determined whether a nuclear pool of
Bcy1 or a nuclear-localized PKA catalytic subunit, such as
Tpk1, interacts with the kinetochore and whether disruption of kinetochore function releases active
Tpk1. It has been demonstrated that loss of one copy of
BCY1 in a diploid strain increases the rate of chromosome loss, suggesting that
Bcy1 may be important for kinetochore function (
Magtanong et al. 2011). How the kinetochore impinges upon the cAMP-PKA pathway and whether this function is conserved in higher eukaryotes will be an interesting subject of future research.